相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multicentre validation of a prognostic index for overall survival in chronic lymphocytic leukaemia
Pietro Bulian et al.
HEMATOLOGICAL ONCOLOGY (2011)
High Serum Thymidine Kinase 1 Level Predicts Poorer Survival in Patients With Chronic Lymphocytic Leukemia
Sergej N. Konoplev et al.
AMERICAN JOURNAL OF CLINICAL PATHOLOGY (2010)
Low CD49d expression and long telomere identify a chronic lymphocytic leukemia subset with highly favourable outcome
Davide Rossi et al.
AMERICAN JOURNAL OF HEMATOLOGY (2010)
An overview of chronic lymphocytic leukaemia biology
M. T. S. Bertilaccio et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Moving from prognostic to predictive factors in chronic lymphocytic leukaemia (CLL)
Thorsten Zenz et al.
BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY (2010)
Prognosis of Binet stage A chronic lymphocytic leukemia patients: the strength of routine parameters
Remi Letestu et al.
BLOOD (2010)
Angiopoietin-2 plasma dosage predicts time to first treatment and overall survival in chronic lymphocytic leukemia
Rossana Maffei et al.
BLOOD (2010)
Soluble CD14 is a novel monocyte-derived survival factor for chronic lymphocytic leukemia cells, which is induced by CLL cells in vitro and present at abnormally high levels in vivo
Martina Seiffert et al.
BLOOD (2010)
Chronic lymphocytic leukaemia: prognostic value of lymphocyte morphological subtypes. A multivariate survival analysis in 146 patients
Teresa Vallespí et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families
Lynn R. Goldin et al.
BRITISH JOURNAL OF HAEMATOLOGY (2010)
Angiopoietin-2 mRNA expression is increased in chronic lymphocytic leukemia patients with poor prognostic features
F. Vrbacky et al.
HEMATOLOGY (2010)
CD38 as a prognostic marker in chronic lymphocytic leukaemia at a single New Zealand centre: patient survival in comparison to age- and sex-matched population data
B. D. Hock et al.
INTERNAL MEDICINE JOURNAL (2010)
Prognostic impact of ZAP-70 expression in chronic lymphocytic leukemia: mean fluorescence intensity T/B ratio versus percentage of positive cells
Francesca M. Rossi et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2010)
CD38 as a molecular compass guiding topographical decisions of chronic lymphocytic leukemia cells
Silvia Deaglio et al.
SEMINARS IN CANCER BIOLOGY (2010)
CLL-like monoclonal B-cell lymphocytosis: Are we all bound to have it?
Lydia Scarfo et al.
SEMINARS IN CANCER BIOLOGY (2010)
Prognostic markers in chronic lymphocytic leukemia: A comprehensive review
Femke Van Bockstaele et al.
BLOOD REVIEWS (2009)
The prognosis of clinical monoclonal B cell lymphocytosis differs from prognosis of Rai 0 chronic lymphocytic leukaemia and is recapitulated by biological risk factors
Davide Rossi et al.
BRITISH JOURNAL OF HAEMATOLOGY (2009)
Brief Report: Natural History of Individuals With Clinically Recognized Monoclonal B-Cell Lymphocytosis Compared With Patients With Rai 0 Chronic Lymphocytic Leukemia
Tait D. Shanafelt et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Guidelines for the diagnosis and treatment of chronic lymphocytic leukemia:: a report from the International Workshop on Chronic Lymphocytic Leukemia updating the National Cancer Institute-Working Group 1996 guidelines
Michael Hallek et al.
BLOOD (2008)
Cancer statistics, 2008
Ahmedin Jemal et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2008)
Combinations of ZAP-70, CD38 and IGHV mutational status as predictors of time to first treatment in CLL
Alison Morilla et al.
LEUKEMIA & LYMPHOMA (2008)
CD38 expression labels an activated subset within chronic lymphocytic leukemia clones enriched in proliferating B cells
Rajendra N. Damle et al.
BLOOD (2007)
Prognostic nomogram and index for overall survival in previously untreated patients with chronic lymphocytic leukemia
William G. Wierda et al.
BLOOD (2007)
Quantitative flow cytometry of ZAP-70 levels in chronic lymphocytic leukemia using molecules of equivalent soluble fluorochrome
Sigi Kay et al.
CYTOMETRY PART B-CLINICAL CYTOMETRY (2006)
ZAP-70 mRNA quantification in B-cell chronic lymphocytic leukaemia
MA Catherwood et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2006)
Genomics of chronic lymphocytic leukemia microRNAs as new players with clinical significance
GA Calin et al.
SEMINARS IN ONCOLOGY (2006)
Additional genetic high-risk features such as 11q deletion, 17p deletion, and V3-21 usage characterize discordance of ZAP-70 and VH mutation status in chronic lymphocytic leukemia
A Kröber et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
ZAP-70 expression and prognosis in chronic lymphocytic leukaemia
JA Orchard et al.
LANCET (2004)
ZAP-70 compared with immunoglobulin heavy-chain gene mutation status as a predictor of disease progression in chronic lymphocytic leukemia
LZ Rassenti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
High frequency of p53 dysfunction and low level of VH mutation in chronic lymphocytic leukemia patients using the VH3-21 gene segment
K Lin et al.
BLOOD (2003)
ZAP-70 expression identifies a chronic lymphocytic leukemia subtype with unmutated immunoglobulin genes, inferior clinical outcome, and distinct gene expression profile
A Wiestner et al.
BLOOD (2003)
ZAP-70 expression as a surrogate for immunoglobulin-variable-region mutations in chronic lymphocytic leukemia
M Crespo et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Chronic lymphocytic leukaemia: one disease or two?
T Hamblin
ANNALS OF HEMATOLOGY (2002)
Somatically mutated Ig VH3-21 genes characterize a new subset of chronic lymphocytic leukemia
G Tobin et al.
BLOOD (2002)
CD38 expression and secondary 17p deletion are important prognostic factors in chronic lymphocytic leukaemia
P Chevallier et al.
BRITISH JOURNAL OF HAEMATOLOGY (2002)
Relation of gene expression phenotype to immunoglobulin mutation genotype in B cell chronic lymphocytic leukemia
A Rosenwald et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2001)
Genomic aberrations and survival in chronic lymphocytic leukemia.
H Döhner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
分享论文
